FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - KIDNEY




Form # 785-1-047

CLIN PATH  DEFINITIONS
     PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

T1 Tumor 2.5 cm or less in greatest dimension limited to the kidney

T2 Tumor more than 2.5 cm in greatest dimension limited to the kidney

T3 Tumor extends into major veins or invades adrenal gland or perinephric tissues but not beyond Gerota's fascia

  T3a Tumor invades adrenal gland or perinephric tissues but not beyond Gerota's fascia

  T3b Tumor grossly extends into renal vein(s) or vena cava below diaphragm

  T3c Tumor grossly extends into vena cava above diaphragm

T4 Tumor invades beyond Gerota's fascia
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in a single lymph node, 2 cm or less in greatest dimension

N2 Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension, or multiple lymph nodes, none more than 5 cm in greatest dimension

N3 Metastasis in a lymph node more than 5 cm in greatest dimension
     DISTANT METASTASIS (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

 CLIN PATH  STAGE GROUPING

I T1 N0 M0

II T2 N0 M0

III T1 N1 M0
      T2 N1 M0
      T3a N0 M0
      T3a N1 M0
      T3b N0 M0
      T3b N1 M0
      T3c N0 M0
      T3c N1 M0

IV T4 Any N M0
      Any T N2 M0
      Any T N3 M0
      Any T Any N M1

Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:
Patient Name: